Processing

Please wait...

Settings

Settings

Goto Application

1. EP3012246 - POLYMORPHIC FORM OF N-[4-(TRIFLUOROMETHIL)BENZYL]-4-METHOXYBUTYRAMIDE

Office
European Patent Office
Application Number 15192055
Application Date 12.11.2008
Publication Number 3012246
Publication Date 27.04.2016
Publication Kind B1
IPC
C07C 235/06
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
235Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
02having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
04the carbon skeleton being acyclic and saturated
06having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
A61K 31/165
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
16Amides, e.g. hydroxamic acids
165having aromatic rings, e.g. colchicine, atenolol, progabide
A61P 25/30
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
30for treating abuse or dependence
CPC
C07C 235/06
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
235Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
02having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
04the carbon skeleton being acyclic and saturated
06having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
C07B 2200/13
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
2200Indexing scheme relating to specific properties of organic compounds
13Crystalline forms, e.g. polymorphs
A61P 25/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
A61P 25/30
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
30for treating abuse or dependence
A61P 25/32
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
30for treating abuse or dependence
32Alcohol-abuse
Applicants LABORATORIO FARM C T S R L
Inventors CACCIAGLIA ROBERTO
FERRARI MASSIMO
Designated States
Title
(DE) POLYMORPHE FORM VON N-[4-(TRIFLUORMETHYL)BENZYL]-4-METHOXYBUTYRAMID
(EN) POLYMORPHIC FORM OF N-[4-(TRIFLUOROMETHIL)BENZYL]-4-METHOXYBUTYRAMIDE
(FR) FORME POLYMORPHE DE N-[4-(TRIFLUOROMÉTHYL)BENZYL]-4-MÉTHOXYBUTYRAMIDE
Abstract
(EN) Crystalline polymorphic form of a compound of formula N-[4-(trifluoromethyl)benzyl]-4-methoxybutyramide is described. The polymorphic form, named polymorphic Form B, can be used in the treatment of drug addiction and alcoholism and have very good stability. Methods for preparing the polymorphic form are also described.
(FR) La présente invention concerne des formes polymorphes cristallines d'un composé représenté par la formule N-[4-(trifluorométhyl)benzyl]-4-méthoxybutyramide. Les deux formes polymorphes, dénommées forme polymorphe A et forme polymorphe B, peuvent être utilisées pour le traitement d'une dépendance médicamenteuse et de l'alcoolisme, et présentent une très bonne stabilité. L'invention concerne également des procédés de préparation des formes polymorphes.
Related patent documents
BRPI0819370This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.